---
title: "AVAX trading at $7.91 near $7.98 resistance at 200-day SMA. Intraday pop of 4.83%, 74% smart money long. MACD momentum..."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299422837.md"
description: "The cryptocurrency AVAX is currently valued at $7.91, approaching a strong resistance barrier near the 200-day moving average of $7.98, experiencing a 4.83% increase during the day. Market analysts suggest that 74% of investors are holding long positions on AVAX. Despite this, the MACD momentum indicator is showing..."
datetime: "2026-09-18T08:45:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299422837.md)
  - [en](https://longbridge.com/en/news/299422837.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299422837.md)
generator: "portal-rs"
---

# AVAX trading at $7.91 near $7.98 resistance at 200-day SMA. Intraday pop of 4.83%, 74% smart money long. MACD momentum...

The cryptocurrency AVAX is currently valued at $7.91, approaching a strong resistance barrier near the 200-day moving average of $7.98, experiencing a 4.83% increase during the day. Market analysts suggest that 74% of investors are holding long positions on AVAX. Despite this, the MACD momentum indicator is showing...

### Related Stocks

- [GAVA.US](https://longbridge.com/en/quote/GAVA.US.md)
- [BAVA.US](https://longbridge.com/en/quote/BAVA.US.md)

## Related News & Research

- [Avalanche: Paxos regulated infrastructure goes live for institutional access - 17 Sep 2026](https://longbridge.com/en/news/299349956.md)
- [India’s Arya.ag to put grain ownership records on Avalanche](https://longbridge.com/en/news/298570602.md)
- [Aave founder pitches ‘Uber path’ for DeFi after Clarity Act fails Senate vote](https://longbridge.com/en/news/299214626.md)
- [Avalanche’s UAE PASS deal is a test of institutional adoption — Can it scale?](https://longbridge.com/en/news/299009413.md)
- [Avalanche, latest crypto treasury platform, set to start trading on Nasdaq as proxy trade evolves](https://longbridge.com/en/news/289490926.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**